Felix Faber
CEO & Founder, MindPeak GmbH
Co-Founder & CEO, Mindpeak GmbH · Hamburg chapter
CEO and co-founder of Mindpeak, the Hamburg AI company automating cancer pathology: 10+ CE-IVD products, $15.3M ZEISS-co-led Series A (2024), 50,000+ patients supported. Previously founded Bytro Labs, merged into Nasdaq-listed Stillfront Group; his companies have generated over $350M in revenue.
Highlights
- Co-founded Mindpeak (2018), a Hamburg AI-pathology company with 10+ CE-IVD-marked products on one deep-learning platform; its tools have supported diagnoses for 50,000+ cancer patients in routine clinical use across the US and EU.
- Raised a $15.3M Series A for Mindpeak (2024), co-led by ZEISS Ventures and InnoVentureFund with AI.FUND and the European Innovation Council Fund, with a cash-flow-positive core business at the time of the round.
- Founded the online-games company Bytro Labs (2008), which merged into Stillfront Group (2013) and listed on Nasdaq Stockholm in 2015, reaching a peak market capitalisation of around $3 billion.
- Two-time RoboCup world champion in robotic soccer with the University of Freiburg, where he specialised in AI in Sven Behnke's Humanoid Robotics group.
Co-founded Mindpeak (2018), a Hamburg AI-pathology company with 10+ CE-IVD-marked products on one deep-learning platform; its tools have supported diagnoses for 50,000+ cancer patients in routine clinical use across the US and EU.. Raised a $15.3M Series A for Mindpeak (2024), co-led by ZEISS Ventures and InnoVentureFund with AI.FUND and the European Innovation Council Fund, with a cash-flow-positive core business at the time of the round.. Founded the online-games company Bytro Labs (2008), which merged into Stillfront Group (2013) and listed on Nasdaq Stockholm in 2015, reaching a peak market capitalisation of around $3 billion.. Two-time RoboCup world champion in robotic soccer with the University of Freiburg, where he specialised in AI in Sven Behnke's Humanoid Robotics group..
About Felix Faber
Felix Faber is the co-founder and CEO of Mindpeak, a Hamburg-based AI company building deep-learning software for pathologists in clinical and pharmaceutical workflows. He holds a BSc in Cognitive Science from the University of Osnabrück and an MSc in Computer Science from the University of Freiburg, where he specialised in AI in Sven Behnke's Humanoid Robotics group and won two RoboCup world championships in robotic soccer.
Before Mindpeak, Faber founded the online-games company Bytro Labs in 2008. Bytro merged with Stillfront Group in 2013, which listed on Nasdaq Stockholm in 2015 and reached a peak market capitalisation of around USD 3 billion. According to pharmaphorum, the companies he has built have generated over USD 350 million in cumulative revenue.
In 2018 he co-founded Mindpeak with Dr. Tobias Lang. The company has released ten or more CE-IVD-marked products on a single deep-learning platform and is distributed via partnerships such as Paige; ZEISS led an investment round in 2024. Faber states Mindpeak's tools have supported diagnoses in more than 50,000 cancer patients across the US and EU, and he was named Hamburg Innovator of the Month in December 2024.
Credentials
- OtherBSc Cognitive Science— University of Osnabrück
- OtherMSc Computer Science (AI)— University of Freiburg
Education
Awards
- Hamburg Innovator of the Month — hamburginvest (2024)
Topics & Expertise
- Cancer Prevention
- Pharmaceuticals & Supplements
- AI in digital pathology
- cancer diagnostics
- explainable AI
- biomarker quantification
- deep learning
- medtech entrepreneurship
Frequently Asked
Who is Felix Faber?
Felix Faber is a German computer scientist and serial entrepreneur, and the co-founder and CEO of Mindpeak GmbH, a Hamburg-based AI company for digital pathology founded in 2018. Before Mindpeak he founded the online-games company Bytro Labs (2008), which merged into the Nasdaq-listed Stillfront Group. The companies he has built have generated over $350 million in cumulative revenue.
What does Felix Faber's company Mindpeak do?
Mindpeak builds deep-learning software that automates histological and immunohistochemical tissue analysis for pathologists in clinical and pharmaceutical workflows. The Hamburg company has released more than 10 CE-IVD-marked products on a single AI platform, and its algorithms were among the first deployed for routine clinical cancer diagnostics in both the US and EU, supporting diagnoses for over 50,000 cancer patients.
How much funding has Mindpeak raised?
In September 2024 Mindpeak raised a $15.3 million Series A, co-led by ZEISS Ventures and InnoVentureFund, with participation from AI.FUND and the European Innovation Council Fund. At the time of the round, CEO Felix Faber's company reported a cash-flow-positive core business and planned to expand its AI pathology portfolio across additional organs, biomarkers and geographies.
What is Felix Faber's background?
Felix Faber holds a BSc in Cognitive Science from the University of Osnabrück and an MSc in Computer Science from the University of Freiburg, where he specialised in AI in Sven Behnke's Humanoid Robotics group and won two RoboCup world championships in robotic soccer. In 2008 he founded Bytro Labs, which merged into Stillfront Group in 2013; Stillfront listed on Nasdaq Stockholm in 2015 and reached a peak market capitalisation of around $3 billion.